Skip to main content
. 2019 Mar 2;78(8):1019–1024. doi: 10.1136/annrheumdis-2018-214697

Figure 1.

Figure 1

Flow chart for the treatment of newly diagnosed or refractory patients with juvenile localised scleroderma according to the clinical subtype. CS, corticosteroid; IT, infrared thermography; LoSCAT, Localized Scleroderma Cutaneous Assessment Tool; MMF, mycophenolate mofetil; MTX, methotrexate; US, ultrasound.